
Orthocare Innovations, Oklahoma City, Oklahoma, has received a significant equity investment from Schooner Capital, Boston, a private investment group. The investment was made in support of the commercial launch of Orthocare's new product pipeline. Terms of the transaction were not disclosed, but Orthocare's founders and executive management will retain significant equity interests in the company, as well as board representation by CEO Doug McCormack; Chief Technology Officer David Boone, CP, MPH, PhD; and Chief Operating Officer Doug Wallace.
McCormack commented, "At Orthocare Innovations, we have built a world-class R&D capability and forged global research partnership to commercialize technologies that will have a transformative effect on the O&P market. Schooner's long-term growth investment philosophy supports our approach to innovation and will accelerate our ability to enhance patient care and improve clinical outcomes."

Copyright © 2007 - 2012 Orthocare Innovations, LLC. All rights reserved.